30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Royalty Pharma PLC (RPRX)

Track

Royalty Pharma PLC has seen significant insider selling activity in the last 90 days, with total sales exceeding $28.8 million. Notably, EVP & CFO Terrance P. Coyne and Officer Marshall Urist have executed multiple planned and proposed sales. This activity occurred following the last earnings report which missed expectations.
Stock chart
Ticker: RPRX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Coyne Terrance P.
EVP & CFO
1 sale — total 3,476,116 USD
Planned sale 26 May 2026
Value US$1,183,775.21 | Price 350.09 | Shares 65,306
Proposed sale 26 May 2026
Value US$590,273.46 | Price 141.56 | Shares 86,194
Planned sale 20 May 2026
Value US$721,837.84 | Price 52.75 | Shares 13,684
Proposed sale 20 May 2026
Value US$721,837.21 | Price 52.75 | Shares 13,684
Planned sale 14 May 2026
Value US$726,137.35 | Price 53.06 | Shares 13,684
Planned sale 14 May 2026
Value US$726,137.35 | Price 53.06 | Shares 13,684
Proposed sale 14 May 2026
Value US$726,137.82 | Price 53.06 | Shares 13,684
Planned sale 14 May 2026
Value US$161,385.00 | Price 53.00 | Shares 3,045
Proposed sale 14 May 2026
Value US$161,385.00 | Price 53.00 | Shares 3,045
Planned sale 28 Apr 2026
Value US$93,334.50 | Price 49.78 | Shares 1,875
Planned sale 28 Apr 2026
Value US$1,638,505.81 | Price 49.78 | Shares 32,916
Proposed sale 28 Apr 2026
Value US$1,723,546.14 | Price 49.54 | Shares 34,791
Planned sale 1 Apr 2026
Value US$1,590,889.53 | Price 48.33 | Shares 32,916
Planned sale 1 Apr 2026
Value US$1,590,889.53 | Price 48.33 | Shares 32,916
Planned sale 1 Apr 2026
Value US$90,622.12 | Price 48.33 | Shares 1,875
Planned sale 1 Apr 2026
Value US$90,622.12 | Price 48.33 | Shares 1,875
Proposed sale 1 Apr 2026
Value US$1,687,015.59 | Price 48.49 | Shares 34,791
Planned sale 23 Mar 2026
Value US$85,366.31 | Price 45.53 | Shares 1,875
Planned sale 23 Mar 2026
Value US$1,498,622.69 | Price 45.53 | Shares 32,916
Proposed sale 23 Mar 2026
Value US$1,586,817.51 | Price 45.61 | Shares 34,791
Proposed sale 19 Mar 2026
Value US$1,662,664.54 | Price 45.53 | Shares 36,518
Proposed sale 18 Mar 2026
Value US$4,600,154.98 | Price 45.79 | Shares 100,462
Proposed sale 4 Mar 2026
Value US$6,496,961.40 | Price 47.43 | Shares 136,980
Planned sale 2 Mar 2026
Value US$27,409.34 | Price 47.01 | Shares 583
Planned sale 2 Mar 2026
Value US$60,303.71 | Price 46.67 | Shares 1,292
Planned sale 2 Mar 2026
Value US$490,314.22 | Price 47.01 | Shares 10,429
Planned sale 2 Mar 2026
Value US$1,049,506.52 | Price 46.67 | Shares 22,487
Proposed sale 2 Mar 2026
Value US$1,651,528.77 | Price 47.47 | Shares 34,791
Planned sale 23 Feb 2026
Value US$84,968.44 | Price 45.32 | Shares 1,875
Planned sale 23 Feb 2026
Value US$1,491,637.91 | Price 45.32 | Shares 32,916
Proposed sale 23 Feb 2026
Value US$1,581,946.77 | Price 45.47 | Shares 34,791
Planned sale 4 Feb 2026
Value US$47,059.27 | Price 43.29 | Shares 1,087
Planned sale 4 Feb 2026
Value US$825,853.45 | Price 43.29 | Shares 19,076
Planned sale 4 Feb 2026
Value US$47,059.27 | Price 43.29 | Shares 1,087
Planned sale 4 Feb 2026
Value US$825,853.45 | Price 43.29 | Shares 19,076
Planned sale 3 Feb 2026
Value US$265,413.00 | Price 42.84 | Shares 6,195
Planned sale 3 Feb 2026
Value US$4,659,583.59 | Price 42.84 | Shares 108,759
Planned sale 3 Feb 2026
Value US$265,413.00 | Price 42.84 | Shares 6,195
Planned sale 3 Feb 2026
Value US$4,659,583.59 | Price 42.84 | Shares 108,759
Proposed sale 3 Feb 2026
Value US$5,805,977.49 | Price 42.97 | Shares 135,117
Planned sale 2 Feb 2026
Value US$245,896.23 | Price 42.08 | Shares 5,843
Planned sale 2 Feb 2026
Value US$245,896.23 | Price 42.08 | Shares 5,843
Planned sale 2 Feb 2026
Value US$4,317,008.55 | Price 42.08 | Shares 102,581
Proposed sale 2 Feb 2026
Value US$4,592,840.64 | Price 42.36 | Shares 108,424
Planned sale 30 Jan 2026
Value US$821,810.00 | Price 41.09 | Shares 20,000
Planned sale 23 Jan 2026
Value US$805,110.00 | Price 40.26 | Shares 20,000
Planned sale 20 Jan 2026
Value US$147,556.50 | Price 39.35 | Shares 3,750
Planned sale 20 Jan 2026
Value US$2,590,383.87 | Price 39.35 | Shares 65,832
Proposed sale 20 Jan 2026
Value US$2,719,960.38 | Price 39.09 | Shares 69,582
Planned sale 16 Jan 2026
Value US$790,346.00 | Price 39.52 | Shares 20,000
Planned sale 9 Jan 2026
Value US$815,634.00 | Price 40.78 | Shares 20,000
Proposed sale 7 Jan 2026
Value US$20,523,645.40 | Price 41.39 | Shares 495,860
Planned sale 2 Jan 2026
Value US$144,058.88 | Price 38.42 | Shares 3,750
Planned sale 2 Jan 2026
Value US$2,528,982.36 | Price 38.42 | Shares 65,832
Planned sale 2 Jan 2026
Value US$769,650.00 | Price 38.48 | Shares 20,000
Proposed sale 2 Jan 2026
Value US$2,703,956.52 | Price 38.86 | Shares 69,582
Planned sale 26 Dec 2025
Value US$786,380.00 | Price 39.32 | Shares 20,000
Planned sale 19 Dec 2025
Value US$767,582.00 | Price 38.38 | Shares 20,000
Planned sale 18 Dec 2025
Value US$1,180,053.32 | Price 38.50 | Shares 30,654
Planned sale 17 Dec 2025
Value US$3,060,280.00 | Price 38.57 | Shares 79,346
Planned sale 16 Dec 2025
Value US$766,420.00 | Price 38.32 | Shares 20,000
Proposed sale 16 Dec 2025
Value US$6,137,600.00 | Price 38.36 | Shares 160,000
Planned sale 15 Dec 2025
Value US$143,850.38 | Price 38.36 | Shares 3,750
Planned sale 15 Dec 2025
Value US$2,525,322.10 | Price 38.36 | Shares 65,832
Proposed sale 15 Dec 2025
Value US$2,680,994.46 | Price 38.53 | Shares 69,582
Planned sale 5 Dec 2025
Value US$714,223.55 | Price 39.15 | Shares 18,242
Planned sale 5 Dec 2025
Value US$913,591.44 | Price 39.15 | Shares 23,334
Planned sale 3 Dec 2025
Value US$4,375,008.00 | Price 39.77 | Shares 110,000
Planned sale 1 Dec 2025
Value US$727,855.80 | Price 39.90 | Shares 18,242
Planned sale 1 Dec 2025
Value US$931,633.02 | Price 39.93 | Shares 23,333
Proposed sale 1 Dec 2025
Value US$1,455,711.60 | Price 39.90 | Shares 36,484
Planned sale 1 Dec 2025
Value US$149,497.50 | Price 39.87 | Shares 3,750
Planned sale 1 Dec 2025
Value US$2,624,458.51 | Price 39.87 | Shares 65,832
Proposed sale 1 Dec 2025
Value US$2,776,321.80 | Price 39.90 | Shares 69,582
Proposed sale 1 Dec 2025
Value US$930,232.37 | Price 19.93 | Shares 46,667
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-28 2026-05-26 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
65,306 -32.7%
350.09
US$1,183,775 		65,306 -32.7% 350.09 US$1,183,775
2026-05-26 2026-05-26 PrS Proposed sale
3.8
Terrance Coyne

Officer

Officer
86,194
141.56
US$590,273 		86,194 141.56 US$590,273
2026-05-21 2026-05-20 PlS Planned sale
3.5
Urist Marshall

EVP, Research & Investments

Officer
96,473 -4.7%
24.77
US$4,197,379 		96,473 -4.7% 24.77 US$4,197,379
2026-05-20 2026-05-20 PrS Proposed sale
3.5
Urist Marshall

Officer

Officer
13,684
52.75
US$721,837 		13,684 52.75 US$721,837
2026-05-15 2026-05-14 PlS Planned sale
3.5
Urist Marshall

EVP, Research & Investments

Officer
13,684 -30.0%
53.06
US$726,137 		13,684 -30.0% 53.06 US$726,137
2026-05-15 2026-05-14 PlS Planned sale
3.5
Urist Marshall

EVP, Research & Investments

Officer
13,684 -30.0%
53.06
US$726,137 		13,684 -30.0% 53.06 US$726,137
2026-05-15 2026-05-14 PlS Planned sale
2.4
Norden Gregory
Non-Executive Director
3,045 -1.6%
53.00
US$161,385 		3,045 -1.6% 53.00 US$161,385
2026-05-14 2026-05-14 PrS Proposed sale
2.4
Norden Gregory

Officer

Officer
3,045
53.00
US$161,385 		3,045 53.00 US$161,385
2026-05-14 2026-05-14 PrS Proposed sale
3.5
Urist Marshall

Officer

Officer
13,684
53.06
US$726,138 		13,684 53.06 US$726,138
2026-04-30 2026-04-28 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
1,875 -4.5%
49.78
US$93,334 		1,875 -4.5% 49.78 US$93,334
2026-04-30 2026-04-28 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
32,916 -100.0%
49.78
US$1,638,506 		32,916 -100.0% 49.78 US$1,638,506
2026-04-28 2026-04-28 PrS Proposed sale
3.8
Terrance Coyne

Officer

Officer
34,791
49.54
US$1,723,546 		34,791 49.54 US$1,723,546
2026-04-02 2026-04-01 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
32,916 -50.0%
48.33
US$1,590,890 		32,916 -50.0% 48.33 US$1,590,890
2026-04-02 2026-04-01 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
32,916 -50.0%
48.33
US$1,590,890 		32,916 -50.0% 48.33 US$1,590,890
2026-04-02 2026-04-01 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
1,875 -4.3%
48.33
US$90,622 		1,875 -4.3% 48.33 US$90,622
2026-04-02 2026-04-01 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
1,875 -4.3%
48.33
US$90,622 		1,875 -4.3% 48.33 US$90,622
2026-04-01 2026-04-01 PrS Proposed sale
3.8
Terrance Coyne

Officer

Officer
34,791
48.49
US$1,687,016 		34,791 48.49 US$1,687,016
2026-03-25 2026-03-23 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
1,875 -4.1%
45.53
US$85,366 		1,875 -4.1% 45.53 US$85,366
2026-03-25 2026-03-23 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
32,916 -33.3%
45.53
US$1,498,623 		32,916 -33.3% 45.53 US$1,498,623
2026-03-23 2026-03-23 PrS Proposed sale
3.8
Terrance Coyne

Officer

Officer
34,791
45.61
US$1,586,818 		34,791 45.61 US$1,586,818
2026-03-19 2026-03-19 PrS Proposed sale
3.8
George Lloyd

Officer

Officer
36,518
45.53
US$1,662,665 		36,518 45.53 US$1,662,665
2026-03-18 2026-03-18 PrS Proposed sale
3.8
George Lloyd

Officer

Officer
100,462
45.79
US$4,600,155 		100,462 45.79 US$4,600,155
2026-03-04 2026-03-04 PrS Proposed sale
3.8
George Lloyd

Officer

Officer
136,980
47.43
US$6,496,961 		136,980 47.43 US$6,496,961
2026-03-04 2026-03-02 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
583 -1.3%
47.01
US$27,409 		583 -1.3% 47.01 US$27,409
2026-03-04 2026-03-02 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
1,292 -2.7%
46.67
US$60,304 		1,292 -2.7% 46.67 US$60,304
2026-03-04 2026-03-02 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
10,429 -9.6%
47.01
US$490,314 		10,429 -9.6% 47.01 US$490,314
2026-03-04 2026-03-02 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
22,487 -17.1%
46.67
US$1,049,507 		22,487 -17.1% 46.67 US$1,049,507
2026-03-02 2026-03-02 PrS Proposed sale
3.8
Terrance Coyne

Officer

Officer
34,791
47.47
US$1,651,529 		34,791 47.47 US$1,651,529
2026-02-25 2026-02-23 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
1,875 -3.8%
45.32
US$84,968 		1,875 -3.8% 45.32 US$84,968
2026-02-25 2026-02-23 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
32,916 -20.0%
45.32
US$1,491,638 		32,916 -20.0% 45.32 US$1,491,638
2026-02-23 2026-02-23 PrS Proposed sale
3.8
Terrance Coyne

Officer

Officer
34,791
45.47
US$1,581,947 		34,791 45.47 US$1,581,947
2026-02-04 2026-02-04 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
1,087 -4.5%
43.29
US$47,059 		1,087 -4.5% 43.29 US$47,059
2026-02-04 2026-02-04 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
19,076 -10.4%
43.29
US$825,853 		19,076 -10.4% 43.29 US$825,853
2026-02-04 2026-02-04 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
1,087 -4.5%
43.29
US$47,059 		1,087 -4.5% 43.29 US$47,059
2026-02-04 2026-02-04 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
19,076 -10.4%
43.29
US$825,853 		19,076 -10.4% 43.29 US$825,853
2026-02-04 2026-02-03 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
6,195 -20.5%
42.84
US$265,413 		6,195 -20.5% 42.84 US$265,413
2026-02-04 2026-02-03 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
108,759 -37.2%
42.84
US$4,659,584 		108,759 -37.2% 42.84 US$4,659,584
2026-02-04 2026-02-03 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
6,195 -20.5%
42.84
US$265,413 		6,195 -20.5% 42.84 US$265,413
2026-02-04 2026-02-03 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
108,759 -37.2%
42.84
US$4,659,584 		108,759 -37.2% 42.84 US$4,659,584
2026-02-03 2026-02-03 PrS Proposed sale
3.8
Terrance Coyne

Officer

Officer
135,117
42.97
US$5,805,977 		135,117 42.97 US$5,805,977
2026-02-04 2026-02-02 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
5,843 -16.2%
42.08
US$245,896 		5,843 -16.2% 42.08 US$245,896
2026-02-04 2026-02-02 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
5,843 -16.2%
42.08
US$245,896 		5,843 -16.2% 42.08 US$245,896
2026-02-04 2026-02-02 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
102,581 -26.0%
42.08
US$4,317,009 		102,581 -26.0% 42.08 US$4,317,009
2026-02-02 2026-02-02 PrS Proposed sale
3.8
Terrance Coyne

Officer

Officer
108,424
42.36
US$4,592,841 		108,424 42.36 US$4,592,841
2026-02-02 2026-01-30 PlS Planned sale
3.5
Urist Marshall

EVP, Research & Investments

Officer
20,000 -100.0%
41.09
US$821,810 		20,000 -100.0% 41.09 US$821,810
2026-01-26 2026-01-23 PlS Planned sale
3.5
Urist Marshall

EVP, Research & Investments

Officer
20,000 -50.0%
40.26
US$805,110 		20,000 -50.0% 40.26 US$805,110
2026-01-23 2026-01-20 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
3,750 -9.4%
39.35
US$147,556 		3,750 -9.4% 39.35 US$147,556
2026-01-23 2026-01-20 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
65,832 -14.3%
39.35
US$2,590,384 		65,832 -14.3% 39.35 US$2,590,384
2026-01-20 2026-01-20 PrS Proposed sale
3.8
Terrance Coyne

Officer

Officer
69,582
39.09
US$2,719,960 		69,582 39.09 US$2,719,960
2026-01-20 2026-01-16 PlS Planned sale
3.5
Urist Marshall

EVP, Research & Investments

Officer
20,000 -33.3%
39.52
US$790,346 		20,000 -33.3% 39.52 US$790,346
2026-01-13 2026-01-09 PlS Planned sale
3.5
Urist Marshall

EVP, Research & Investments

Officer
20,000 -25.0%
40.78
US$815,634 		20,000 -25.0% 40.78 US$815,634
2026-01-07 2026-01-07 PrS Proposed sale
3.8
George Lloyd

Officer

Officer
495,860
41.39
US$20,523,645 		495,860 41.39 US$20,523,645
2026-01-06 2026-01-02 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
3,750 -8.6%
38.42
US$144,059 		3,750 -8.6% 38.42 US$144,059
2026-01-06 2026-01-02 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
65,832 -12.5%
38.42
US$2,528,982 		65,832 -12.5% 38.42 US$2,528,982
2026-01-06 2026-01-02 PlS Planned sale
3.5
Urist Marshall

EVP, Research & Investments

Officer
20,000 -20.0%
38.48
US$769,650 		20,000 -20.0% 38.48 US$769,650
2026-01-02 2026-01-02 PrS Proposed sale
3.8
Terrance Coyne

Officer

Officer
69,582
38.86
US$2,703,957 		69,582 38.86 US$2,703,957
2025-12-29 2025-12-26 PlS Planned sale
3.5
Urist Marshall

EVP, Research & Investments

Officer
20,000 -16.7%
39.32
US$786,380 		20,000 -16.7% 39.32 US$786,380
2025-12-22 2025-12-19 PlS Planned sale
3.5
Urist Marshall

EVP, Research & Investments

Officer
20,000 -14.3%
38.38
US$767,582 		20,000 -14.3% 38.38 US$767,582
2025-12-19 2025-12-18 PlS Planned sale
3.8
Lloyd George W.

EVP, Investments & CLO

Officer
30,654 -100.0%
38.50
US$1,180,053 		30,654 -100.0% 38.50 US$1,180,053
2025-12-19 2025-12-17 PlS Planned sale
3.8
Lloyd George W.

EVP, Investments & CLO

Officer
79,346 -72.1%
38.57
US$3,060,280 		79,346 -72.1% 38.57 US$3,060,280
2025-12-17 2025-12-16 PlS Planned sale
3.5
Urist Marshall

EVP, Research & Investments

Officer
20,000 -12.5%
38.32
US$766,420 		20,000 -12.5% 38.32 US$766,420
2025-12-16 2025-12-16 PrS Proposed sale
Sandy Lamm LLC

Officer

Officer
160,000
38.36
US$6,137,600 		160,000 38.36 US$6,137,600
2025-12-17 2025-12-15 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
3,750 -7.9%
38.36
US$143,850 		3,750 -7.9% 38.36 US$143,850
2025-12-17 2025-12-15 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
65,832 -11.1%
38.36
US$2,525,322 		65,832 -11.1% 38.36 US$2,525,322
2025-12-15 2025-12-15 PrS Proposed sale
3.8
Terrance Coyne

Officer

Officer
69,582
38.53
US$2,680,994 		69,582 38.53 US$2,680,994
2025-12-09 2025-12-05 PlS Planned sale
3.5
Urist Marshall

EVP, Research & Investments

Officer
18,242 -71.1%
39.15
US$714,224 		18,242 -71.1% 39.15 US$714,224
2025-12-09 2025-12-05 PlS Planned sale
3.5
Urist Marshall

EVP, Research & Investments

Officer
23,334 -12.7%
39.15
US$913,591 		23,334 -12.7% 39.15 US$913,591
2025-12-05 2025-12-03 PlS Planned sale
3.8
Lloyd George W.

EVP, Investments & CLO

Officer
110,000 -50.0%
39.77
US$4,375,008 		110,000 -50.0% 39.77 US$4,375,008
2025-12-03 2025-12-01 PlS Planned sale
3.5
Urist Marshall

EVP, Research & Investments

Officer
18,242 -41.6%
39.90
US$727,856 		18,242 -41.6% 39.90 US$727,856
2025-12-03 2025-12-01 PlS Planned sale
3.5
Urist Marshall

EVP, Research & Investments

Officer
23,333 -11.3%
39.93
US$931,633 		23,333 -11.3% 39.93 US$931,633
2025-12-03 2025-12-01 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
3,750 -7.4%
39.87
US$149,498 		3,750 -7.4% 39.87 US$149,498
2025-12-03 2025-12-01 PlS Planned sale
3.8
Coyne Terrance P.

EVP & CFO

Officer
65,832 -10.0%
39.87
US$2,624,459 		65,832 -10.0% 39.87 US$2,624,459
2025-12-01 2025-12-01 PrS Proposed sale
3.5
Urist Marshall

Officer

Officer
36,484
39.90
US$1,455,712 		36,484 39.90 US$1,455,712
2025-12-01 2025-12-01 PrS Proposed sale
3.8
Terrance Coyne

Officer

Officer
69,582
39.90
US$2,776,322 		69,582 39.90 US$2,776,322
2025-12-01 2025-12-01 PrS Proposed sale
Sandy Lamm LLC

Officer

Officer
46,667
19.93
US$930,232 		46,667 19.93 US$930,232
Explore more

More insider trading research around Royalty Pharma PLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America